MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma (Q34784133)

4 August 2017

title

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma (English)

1 reference

4 August 2017

3

1 reference

4 August 2017

F Fornari

1

0 references

Angelo Veronese

A Veronese

4

0 references

Laura Gramantieri

L Gramantieri

2

0 references

Catia Giovannini

C Giovannini

8

0 references

Carlo Maria Croce

9

C M Croce

1 reference

4 August 2017

6

G A Calin

1 reference

4 August 2017

S Sabbioni

5

1 reference

4 August 2017

G L Grazi

7

1 reference

4 August 2017

L Bolondi

10

1 reference

4 August 2017

M Negrini

11

1 reference

4 August 2017

language of work or name

English

0 references

publication date

2 June 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

27

1 reference

4 August 2017

issue

43

1 reference

4 August 2017

page(s)

5651-5661

1 reference

Regulation of p27Kip1 by miRNA 221/222 in glioblastoma

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Expression and hypermethylation of p27 kip1 in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Screening for hepatocellular carcinoma in cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Primary liver cancer: worldwide incidence and trends

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Management of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

MicroRNA signatures in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Extensive modulation of a set of microRNAs in primary glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

miR-15 and miR-16 induce apoptosis by targeting BCL2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

The role of microRNA genes in papillary thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Reduced p27Kip1 expression in hepatocellular carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Expression of p57/Kip2 protein in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

RAS is regulated by the let-7 microRNA family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Silencing of microRNAs in vivo with 'antagomirs'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Expression profiling identifies microRNA signature in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Negative regulators of cyclin-dependent kinases and their roles in cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

MicroRNAs in human cancer: from research to therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

c-Myc-regulated microRNAs modulate E2F1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.178

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.178

1 reference

Dimensions Publication ID

4 August 2017

1019172601

0 references

1 reference